BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4048763)

  • 1. Primary Sjögren's syndrome treated with Efamol/efavit. A double-blind cross-over investigation.
    Webb J; McCredie M
    Rheumatol Int; 1985; 5(4):191. PubMed ID: 4048763
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary Sjögren's syndrome treated with Efamol/Efavit. A double-blind cross-over investigation.
    Manthorpe R; Hagen Petersen S; Prause JU
    Rheumatol Int; 1984; 4(4):165-7. PubMed ID: 6385206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Sjögren's syndrome: an overview.
    Manthorpe R; Prause JU
    Scand J Rheumatol Suppl; 1986; 61():237-41. PubMed ID: 3296150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with primary Sjögren's syndrome treated for two months with evening primrose oil.
    Oxholm P; Manthorpe R; Prause JU; Horrobin D
    Scand J Rheumatol; 1986; 15(2):103-8. PubMed ID: 3529370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential fatty acid and prostaglandin metabolism in Sjögren's syndrome, systemic sclerosis and rheumatoid arthritis.
    Horrobin DF
    Scand J Rheumatol Suppl; 1986; 61():242-5. PubMed ID: 3296151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gammalinolenic acid treatment of fatigue associated with primary Sjögren's syndrome.
    Theander E; Horrobin DF; Jacobsson LT; Manthorpe R
    Scand J Rheumatol; 2002; 31(2):72-9. PubMed ID: 12109650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of oral linoleic acid and gamma-linolenic acid (Efamol [G]).
    Strong AM; Campbell A; Thomson J
    Br J Clin Pract; 1985; 39(11-12):444-5. PubMed ID: 4092010
    [No Abstract]   [Full Text] [Related]  

  • 8. Leg ulceration and Efamol.
    Morrison CS
    N Z Med J; 1986 Sep; 99(809):684. PubMed ID: 3463912
    [No Abstract]   [Full Text] [Related]  

  • 9. Leg ulceration and Efamol.
    Simpson LO
    N Z Med J; 1986 Nov; 99(813):867. PubMed ID: 3466083
    [No Abstract]   [Full Text] [Related]  

  • 10. Leg ulcers and Efamol.
    Morrison CS
    N Z Med J; 1986 Dec; 99(815):957-8. PubMed ID: 3468432
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors.
    Puolakka J; Mäkäräinen L; Viinikka L; Ylikorkala O
    J Reprod Med; 1985 Mar; 30(3):149-53. PubMed ID: 3839018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of atopic eczema with evening primrose oil.
    Lovell CR; Burton JL; Horrobin DF
    Lancet; 1981 Jan; 1(8214):278. PubMed ID: 6109930
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of rheumatoid arthritis with prostaglandin E1 precursors cis-linoleic acid and gamma-linolenic acid.
    Hansen TM; Lerche A; Kassis V; Lorenzen I; Søndergaard J
    Scand J Rheumatol; 1983; 12(2):85-8. PubMed ID: 6304871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of premenstrual syndrome with essential fatty acids (evening primrose oil)].
    Bordoni A; Biagi PL; Turchetto E; Serroni P; De Jaco AP; Orlandi C
    G Clin Med; 1987 Jan; 68(1):23-8. PubMed ID: 3609594
    [No Abstract]   [Full Text] [Related]  

  • 15. Evening primrose seed oil in ichthyosis vulgaris.
    Chalmers RJ; Shuster S
    Lancet; 1983 Jan; 1(8318):236-7. PubMed ID: 6130264
    [No Abstract]   [Full Text] [Related]  

  • 16. Essential fatty acid metabolism in diseases of connective tissue with special reference to scleroderma and to Sjogren's syndrome.
    Horrobin DF
    Med Hypotheses; 1984 Jul; 14(3):233-47. PubMed ID: 6088955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet, nutrition, and allergy in atopic dermatitis.
    Hanifin JM
    J Am Acad Dermatol; 1983 May; 8(5):729-31. PubMed ID: 6863636
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of action of polyunsaturated fatty acids in rheumatoid arthritis.
    Watson J; Madhok R; Wijelath E; Capell HA; Gillespie J; Smith J; Byars ML
    Biochem Soc Trans; 1990 Apr; 18(2):284-5. PubMed ID: 2379720
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients.
    Aragona P; Bucolo C; Spinella R; Giuffrida S; Ferreri G
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4474-9. PubMed ID: 16303936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ineffectiveness of Naudicelle in intermittent claudication].
    Olsson AG; Kirstein P; Eklund B; Johnsson H; Walldius G
    Lakartidningen; 1984 Dec; 81(51):4855-7. PubMed ID: 6394928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.